Skip to content

4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile

C23H17N7OS — CID 171848297

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile
SMILESN#Cc1ccccc1Sc1cc(-c2cnn([C@H]3CCC(=O)NC3)c2)cn2ncc(C#N)c12
InChIInChI=1S/C23H17N7OS/c24-8-15-3-1-2-4-20(15)32-21-7-16(13-30-23(21)17(9-25)10-28-30)18-11-27-29(14-18)19-5-6-22(31)26-12-19/h1-4,7,10-11,13-14,19H,5-6,12H2,(H,26,31)/t19-/m0/s1
InChIKeyAPIYCVVMDSYZEA-IBGZPJMESA-N
MW439.50 g/mol
LogP3.54
Rot. Bonds4

About 4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile

4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile (PubChem CID 171848297) has the molecular formula C23H17N7OS and a molecular weight of 439.50 g/mol. Its IUPAC name is 4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile.

Molecular Properties

Compound Name4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile
PubChem CID171848297
Molecular FormulaC23H17N7OS
Molecular Weight439.50 g/mol
Exact Mass439.12
IUPAC Name4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile
SMILESN#Cc1ccccc1Sc1cc(-c2cnn([C@H]3CCC(=O)NC3)c2)cn2ncc(C#N)c12
InChIInChI=1S/C23H17N7OS/c24-8-15-3-1-2-4-20(15)32-21-7-16(13-30-23(21)17(9-25)10-28-30)18-11-27-29(14-18)19-5-6-22(31)26-12-19/h1-4,7,10-11,13-14,19H,5-6,12H2,(H,26,31)/t19-/m0/s1
InChIKeyAPIYCVVMDSYZEA-IBGZPJMESA-N
XLogP3.54
TPSA111.80 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms32
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500439.50
LogP ≤ 53.54
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile?
The IUPAC name of 4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile (CID 171848297) is 4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile.
What is the SMILES notation for 4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile?
The canonical SMILES for 4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile is N#Cc1ccccc1Sc1cc(-c2cnn([C@H]3CCC(=O)NC3)c2)cn2ncc(C#N)c12.
What is the InChIKey of 4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile?
The InChIKey is APIYCVVMDSYZEA-IBGZPJMESA-N. The full InChI is InChI=1S/C23H17N7OS/c24-8-15-3-1-2-4-20(15)32-21-7-16(13-30-23(21)17(9-25)10-28-30)18-11-27-29(14-18)19-5-6-22(31)26-12-19/h1-4,7,10-11,13-14,19H,5-6,12H2,(H,26,31)/t19-/m0/s1.
What are the key properties of 4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile?
4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile has a molecular weight of 439.50 g/mol, XLogP of 3.54, 4 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(2-cyanophenyl)sulfanyl-6-[1-[(3S)-6-oxopiperidin-3-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile is sourced from PubChem (CID 171848297), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.